Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 4
- 13F valueReported value at the end of Q2 2026
- $39.0K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding VXRT, Q2 2026
No superinvestor reported holding VXRT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Vaxart, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing) | May 22 | 4 days | Watson W. MarkDirector | PPurchase | +10.0K | $0.65 | +$6.50K | +8.1%134.1K after | |
| Dec 5, 2025 (view filing)5:46 PM ET | Nov 17 | 18 daysLate | Watson W. MarkDirector | PPurchase | +20.0K | $0.4093 | +$8.19K | +19.2%124.1K after | 2 lots |
| Nov 21, 2025 (view filing)1:21 PM ET | Nov 17 | 4 daysLate | Heron Elaine JDirector | PPurchase | +40.0K | $0.398 | +$15.9K | +70.7%96.6K after | 2 lots |
| Aug 19, 2025 (view filing)4:06 PM ET | Jul 17-Aug 15 | 33 daysLate | Finney KevinDirector | PPurchase | +166.7K | $0.3716 | +$61.9K | +437.4%204.8K after | 6 lots |
| Jul 31, 2025 (view filing)8:38 PM ET | Jul 29 | 2 days | Watson W. MarkDirector | PPurchase | +10.0K | $0.405 | +$4.05K | +10.6%104.1K after | |
| May 19, 2025 (view filing)6:49 PM ET | May 19 | Same day | Lo StevenPresident, Chief Exec Officer | PPurchase | +100.0K | $0.49 | +$49.0K | New position100.0K after | |
| Jun 20, 2024 (view filing) | Jun 18 | 2 days | Watson W. MarkDirector | PPurchase | +20.0K | $0.68 | +$13.6K | +34.4%78.1K after | |
| Dec 28, 2022 (view filing) | Dec 28 | Same day | Watson W. MarkDirector | PPurchase | +20.0K | $0.76 | +$15.2K | New position20.0K after | |
| Oct 7, 2022 (view filing) | Jan 10 | 270 daysLate | Yedid Robert A.Director | SSale | −1.50K | $6.01 | −$9.02K | −100.0%0 after | |
| Jun 23, 2022 (view filing) | Jun 22 | 1 day | Ahmad FuadInterim CFO | PPurchase | +5.00K | $3.22 | +$16.1K | New position5.00K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Vaxart, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Heritage Wealth Advisors | 29,655 | $17.9K | 0.00% | 00.0% | Unchanged |
| LVM Capital Management Ltd | 25,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Kingswood Wealth Advisors, LLC | 10,005 | $6.05K | 0.00% | +10,005 | New |
| Archer Investment Corp | 30 | $18 | 0.00% | +15+100.0% | Added |